PAVmed (PAVM) Revenue (2021 - 2025)

PAVmed's (PAVM) quarterly Revenue came in at $81000.0 in Q4 2025, up 710.0% year-on-year from $10000.0 in Q4 2024, and up 1520.0% quarter-over-quarter from $5000.0 in Q3 2025.

PAVmed (PAVM) Revenue (2021 - 2025) Analysis & Trends

PAVmed's Revenue history runs 5 years deep, the most recent figure standing at $81000.0 for Q4 2025.

  • On a quarterly basis, Revenue rose 710.0% year-over-year to $81000.0 in Q4 2025; TTM through Dec 2025 was $100000.0, a 96.72% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 96.66% from the prior year.
  • Revenue improved to $81000.0 in Q4 2025 per PAVM's latest filing, from $5000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.0 million in Q4 2023 and bottomed at $5000.0 in Q3 2025.
  • The 5-year median for Revenue is $177500.0 (2022), against an average of $339250.0.
  • Across the five-year window, Revenue surged 940.79% in 2023 and sank 99.39% in 2025, its largest moves.
  • Year by year, Revenue stood at $300000.0 in 2021, then sank by 62.67% to $112000.0 in 2022, then surged by 836.61% to $1.0 million in 2023, then plunged by 99.05% to $10000.0 in 2024, then soared by 710.0% to $81000.0 in 2025.
  • Per Business Quant, the three latest PAVM Revenue figures stand at $81000.0 (Q4 2025), $5000.0 (Q3 2025), and $6000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 11.16 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 6.02 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 9.81 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.65 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.19 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 4.57 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 5.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 PAVmed 9.85 Mn -3.35 Mn -4,000.00 81,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 81,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 8,000.00
Dec 31, 2024 10,000.00
Jun 30, 2024 979,000.00
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.05 Mn
Sep 30, 2023 791,000.00
Jun 30, 2023 166,000.00
Mar 31, 2023 446,000.00
Dec 31, 2022 112,000.00
Sep 30, 2022 76,000.00
Mar 31, 2022 189,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 200,000.00